default author photo

Amy Li

Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research

77 Massachusetts Avenue

50 Memorial Drive

Cambridge, MA 02139-4307

United States

Massachusetts Institute of Technology (MIT) - Department of Biology

77 Massachusetts Ave

Building 68-132

Cambridge, MA 02139

United States

Harvard Medical School

25 Shattuck St

Boston, MA 02115

United States

SCHOLARLY PAPERS

3

DOWNLOADS

254

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Antigen Dominance Hierarchies Shape TCF1+ Progenitor CD8 T Cell Phenotypes in Tumors

Number of pages: 89 Posted: 20 Jan 2021
Megan Burger, Amanda M. Cruz, Grace E. Crossland, Giorgio Gaglia, Cecily C. Ritch, Sarah E. Blatt, Arjun Bhutkar, David Canner, Tamina Kienka, Sara Tavana, Andrea Garmilla, Jason Schenkel, Michelle Hillman, Izumi de los Rios Kobara, Amy Li, William Hwang, Peter Westcott, Aviv Regev, Sandro Santagata and Tyler E. Jacks
Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Sanofi - Massachusetts, Harvard Medical School - Department of Pathology, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, MIT McGovern Institute for Brain Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard Medical School - Department of Pathology and Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research
Downloads 132 (551,165)

Abstract:

Loading...

TCF1; neoantigen; immunodominance; CCR6; Tc17; vaccine; lung cancer

2.

Longitudinal Single Cell Profiling of Regulatory T Cells Identifies IL-33 as a Driver of Tumor Immunosuppression

Number of pages: 88 Posted: 19 Mar 2019
Amy Li, Rebecca H. Herbst, David Canner, Jason M. Schenkel, Olivia C. Smith, Jonathan Y. Kim, Michelle Hillman, Arjun Bhutkar, Michael S. Cuoco, C. Garrett Rappazzo, Patricia Rogers, Celeste Dang, Livnat Jerby-Arnon, Orit Rozenblatt-Rosen, Le Cong, Michael Birnbaum, Aviv Regev and Tyler E. Jacks
Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard Medical School, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology and Harvard University - Broad Institute, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology and Harvard University - Broad Institute, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology and Harvard University - Broad Institute, Massachusetts Institute of Technology and Harvard University - Broad Institute, Stanford University - Department of Genetics, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research and Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research
Downloads 69 (883,195)

Abstract:

Loading...

3.

Increased Dysfunction of Tumor Specific TCF-1+ CD8+ T Cells Associated with Increase in Non-Cycling TCF-1+ SlamF6- Cells Subsets Revealed by Single Cell Analysis

Number of pages: 55 Posted: 21 Oct 2020
Jason Schenkel, Rebecca Herbst, David Canner, Michelle Hillman, Amy Li, Olivia C. Smith, Jonathan Y. Kim, Peter Westcott, William Hwang, William Freed-Pastor, George Eng, Mike Cuoco, Patricia Rogers, Jin K. Park, Megan Burger, Orit Rozenblatt-Rosen, Le Cong, Kristen Pauken, Aviv Regev and Tyler E. Jacks
Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard University - Harvard Medical School, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology and Harvard University - Broad Institute, Massachusetts Institute of Technology and Harvard University - Broad Institute, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology and Harvard University - Broad Institute, Stanford University - Department of Genetics, Harvard Medical School - Department of Immunology, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research and Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research
Downloads 53 (1,031,043)

Abstract:

Loading...

T cell dysfunction, T cell subsets, TCF-1+ CD8 T cells, Lung Adenocarcinoma, T cell heterogeneity